(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.
(1) Anshuman Jamdade, Mahatma Gandhi University of Medical Sciences and Technology, India.
(2) Chin-Mu Hsu, China Medical University, Taiwan.
(3) Hsi-feng Tu, National Yang-Ming University Hospital, Taiwan.
(1) Manoj Kumar Saurabh, Aii India Institute of Medical Sciences, India.
(2) Soumyadev Sarkar, Kansas State University, United States of America.
Open Peer Review Policy: Click Here
Average Peer review marks at initial stage: 6.33/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_2 (Chin-Mu Hsu, Taiwan) | File 1 | NA
Stage 2 | Peer review report_3 (Hsi-feng Tu, Taiwan) | File 1 | NA
Stage 3 | Comment_Editor_1_v1 | File 1 | NA